Bristol-Myers Squibb
In David Abrams's portfolio · Abrams Capital Management
Ticker BMY.RT
Not in the portfolio as of Q3 2026. Every quarter it shows up in a Abrams Capital Management 13F, newest first.
| Quarter | Activity | Shares | Weight |
|---|---|---|---|
| Q1 2021 | Sell | 0 | |
| Q4 2020 | Add 68% | 24,800,355 | 0.5% |
| Q3 2020 | Reduce 36% | 14,800,355 | 1.1% |
| Q2 2020 | No change | 23,202,869 | 2.7% |
| Q1 2020 | No change | 23,202,869 | 3.5% |
| Q4 2019 | Buy | 23,202,869 | 2.2% |
Price is the position's value divided by its shares, at the end of each quarter. Share counts are as filed; when a stock split happened, the change is measured on split-adjusted shares.